Ma, Jun
Gan, Shaolei
Shu, Ruming
Zhou, Liangbin
Chen, Shangsi
Funding for this research was provided by:
Jiangxi Borayer Biotechnology Ltd.
Article History
Received: 2 September 2025
Accepted: 7 November 2025
First Online: 23 December 2025
Declarations
:
: Authors Jun Ma, Shaolei Gan, and Ruming Shu are employees of Jiangxi Borayer Biotechnology Ltd., the company that manufactures and commercializes the Borayerflo hemostatic agent evaluated in this study. This constitutes a significant financial conflict of interest. The other authors declare no competing interests.